GLIMIHIR-M2: Metformin Hydrochloride & Glimepiride Tablets IP

GLIMIHIR-M2 is a combined oral anti-diabetic medication used to help control blood sugar levels in adults with type 2 diabetes mellitus. This dual-action formula combines two effective ingredients to improve glycemic control when diet, exercise, and single-agent therapy are not sufficient.

Key Specifications

• Active Ingredients: Metformin Hydrochloride (Prolonged Release) and Glimepiride.

• Brand Name: GLIMIZIR-M2.

• Packaging: 10 x 10 Tablets (100 tablets per box).

• Standard: IP (Indian Pharmacopoeia).

• Classification: Prescription-only (Rx) medication.

Product Highlights

• Prolonged Release Technology: The Metformin component is formulated for prolonged release, which helps maintain steady blood levels and often reduces gastrointestinal side effects compared to immediate-release versions.

• Synergistic Effect: Glimepiride stimulates the pancreas to produce more insulin, while Metformin improves the body’s sensitivity to insulin and reduces glucose production in the liver.

• Convenient Management: By combining two medications into one tablet, GLIMIZIR-M2 simplifies the daily treatment regimen for improved patient adherence.

Medical Disclaimer: This medication should only be taken under the guidance and prescription of a qualified medical professional. It is important to monitor your blood sugar regularly while on this therapy. Discuss potential side effects, including the risk of hypoglycemia (low blood sugar), with your doctor.